Corvus Pharmaceuticals Inc buy Barclays PLC
Start price
20.01.26
/
50%
€18.30
Target price
20.01.27
-
Performance (%)
-29.54%
Price
13.04.26
?
Summary
This prediction is currently active. The prediction for Corvus Pharmaceuticals Inc disappoints with a performance of -29.54%. This prediction currently runs until 20.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | 8.612% | 8.612% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Barclays_PLC for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CRVS provided by MarketBeat